AI Article Synopsis
- Acute massive pulmonary thromboembolism is a serious medical condition that requires immediate treatment to reduce the risk of death, with a lower dose of the thrombolytic alteplase showing effectiveness while minimizing bleeding risks.
- A case of massive pulmonary thromboembolism was successfully treated using advanced cardiac life support, anticoagulants, and low-dose thrombolytics following cardiopulmonary arrest.
- Ongoing care for such patients includes the use of low-dose thrombolytics for clot resolution and a continuation of standard oral anticoagulants for six months to maintain health.
Article Abstract
Introduction: and importance: Acute massive pulmonary thromboembolism is a potentially life-threatening condition requiring urgent management to decrease mortality. Although the standard dose of systemic thrombolysis with alteplase is 100 mg, half the dose of alteplase can be used to break up clots successfully, especially if bleeding is a concern.
Case Presentation: We report a case of massive pulmonary thromboembolism presenting with cardiopulmonary arrest, successfully managed with advanced cardiac life support, anticoagulants, and low-dose thrombolytics.
Clinical Discussion: Management of massive pulmonary thromboembolism includes medical thrombolysis along with maintenance of hemodynamic stability. Our patient was successfully managed with low-dose thrombolytics and was continued with standard oral anticoagulants for 6 months.
Conclusion: In patients of acute massive pulmonary thromboembolism, a low dose of the thrombolytic agent can achieve complete resolution of the thrombus with less bleeding risk.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577846 | PMC |
| http://dx.doi.org/10.1016/j.amsu.2022.104742 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!